|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Guardant Health, Inc. (GH) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
130,000,000 |
| Market
Cap: |
N/A |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$0 - $0 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Guardant Health is a precision oncology company focused on helping conquer cancer globally through use of its proprietary blood-based tests, data sets and analytics. Co. is engaged in the clinical liquid biopsy market with its Guardant360 and GuardantOMNI tests. Co.'s Guardant360 test is a molecular diagnostic test measuring a number of cancer-related genes and its GuardantOMNI test has a 500-gene panel, both of which analyze circulating tumor DNA in blood. In addition, Co. is developing tests from its LUNAR-1 program for minimal residual disease and recurrence detection in cancer survivors, and its LUNAR-2 program for early detection of cancer.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
2,187 |
| Total Buy Value |
$0 |
$0 |
$0 |
$38,963 |
| Total People Bought |
0 |
0 |
0 |
1 |
| Total Buy Transactions |
0 |
0 |
0 |
1 |
| Total Shares Sold |
304,691 |
544,207 |
689,737 |
695,837 |
| Total Sell Value |
$18,109,127 |
$30,143,475 |
$36,880,688 |
$37,040,968 |
| Total People Sold |
6 |
8 |
8 |
8 |
| Total Sell Transactions |
10 |
24 |
38 |
42 |
| End Date |
2025-08-03 |
2025-05-02 |
2024-11-01 |
2023-11-02 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Mignone Roberto |
Director |
– • – |
2025-10-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,167 |
3,167 |
|
- |
|
| Potter Myrtle S |
Director |
– • – |
2025-10-17 |
4 |
S |
$66.95 |
$1,741 |
D/D |
(26) |
18,324 |
|
- |
|
| Tariq Musa |
Director |
– • – |
2025-10-17 |
4 |
S |
$66.95 |
$7,766 |
D/D |
(116) |
7,725 |
|
- |
|
| Hidalgo Medina Manuel |
Director |
– • – |
2025-10-17 |
4 |
OE |
$0.00 |
$0 |
D/D |
232 |
1,315 |
|
- |
|
| Tariq Musa |
Director |
– • – |
2025-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
250 |
7,841 |
|
- |
|
| Potter Myrtle S |
Director |
– • – |
2025-10-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
69 |
18,350 |
|
- |
|
| Eagle Craig |
Chief Medical Officer |
• – – |
2025-10-01 |
4 |
D |
$62.65 |
$440,116 |
D/D |
(7,025) |
44,316 |
|
- |
|
| Eagle Craig |
Chief Medical Officer |
• – – |
2025-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,859 |
51,341 |
|
- |
|
| Talasaz Amirali |
Co-Chief Executive Officer |
• • – |
2025-10-01 |
4 |
D |
$62.65 |
$761,949 |
D/D |
(12,162) |
1,997,874 |
|
- |
|
| Talasaz Amirali |
Co-Chief Executive Officer |
• • – |
2025-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,997 |
2,010,036 |
|
- |
|
| Eltoukhy Helmy |
Co-Chief Executive Officer |
• • – |
2025-10-01 |
4 |
D |
$62.65 |
$761,949 |
D/D |
(12,162) |
2,137,708 |
|
- |
|
| Eltoukhy Helmy |
Co-Chief Executive Officer |
• • – |
2025-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
23,997 |
2,149,870 |
|
- |
|
| Freeman Chris |
Chief Commercial Officer |
• – – |
2025-10-01 |
4 |
D |
$62.65 |
$359,611 |
D/D |
(5,740) |
57,439 |
|
- |
|
| Freeman Chris |
Chief Commercial Officer |
• – – |
2025-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,550 |
63,179 |
|
- |
|
| Bell Michael Brian |
Chief Financial Officer |
• – – |
2025-10-01 |
4 |
D |
$62.65 |
$482,092 |
D/D |
(7,695) |
52,127 |
|
- |
|
| Bell Michael Brian |
Chief Financial Officer |
• – – |
2025-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,181 |
59,822 |
|
- |
|
| Kalia Kumud |
Chief Information Officer |
• – – |
2025-10-01 |
4 |
D |
$62.65 |
$335,052 |
D/D |
(5,348) |
24,365 |
|
- |
|
| Kalia Kumud |
Chief Information Officer |
• – – |
2025-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,549 |
29,713 |
|
- |
|
| Saia John G. |
Chief Legal Officer |
• – – |
2025-10-01 |
4 |
D |
$62.65 |
$465,552 |
D/D |
(7,431) |
52,168 |
|
- |
|
| Saia John G. |
Chief Legal Officer |
• – – |
2025-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,167 |
59,599 |
|
- |
|
| Chudova Darya |
Chief Technology Officer |
• – – |
2025-10-01 |
4 |
D |
$62.65 |
$511,412 |
D/D |
(8,163) |
89,390 |
|
- |
|
| Chudova Darya |
Chief Technology Officer |
• – – |
2025-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,104 |
97,553 |
|
- |
|
| Monroe Terilyn J. |
Chief People Officer |
• – – |
2025-10-01 |
4 |
D |
$62.65 |
$332,672 |
D/D |
(5,310) |
26,087 |
|
- |
|
| Monroe Terilyn J. |
Chief People Officer |
• – – |
2025-10-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
10,477 |
31,397 |
|
- |
|
| Talasaz Amirali |
Co-Chief Executive Officer |
• • – |
2025-09-30 |
4 |
D |
$62.48 |
$152,451 |
D/D |
(2,440) |
1,986,039 |
|
- |
|
1041 Records found
|
|
Page 1 of 42 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
